Abbott Laboratories
NYSE: ABT
$104.02
Closing Price on July 5, 2024
ABT Chart and Intraday Price
ABT Company Data
Asset Type | Stock |
Exchange | NYSE |
Currency | USD |
Country | USA |
Sector | LIFE SCIENCES |
Industry | PHARMACEUTICAL PREPARATIONS |
Address | 100 ABBOTT PARK ROAD, ABBOTT PARK, IL, US |
Fiscal Year End | December |
Latest Quarter | 12/31/2023 |
Market Cap | 205,827.06M USD |
Shares Outstanding | 1,735,180,000 |
ABT Articles
24/7 Insights AI stocks are facing headwinds and sky high valuations are cooling down J.P. Morgan’s top picks are in May are stable, established brands 2 legendary, high-yield dividend stocks Wall...
Published:
Here is an assessment of how safe the dividend at AbbVie appears to be based on a variety of metrics, including its status as a Dividend Aristocrat.
Published:
Here is an assessment of how safe the dividend at Abbott Laboratories appears to be based on a variety of metrics, including its status as a Dividend Aristocrat.
Published:
These eight top Dividend Aristocrats pay among the biggest dividends in the sectors that typically do well during a recession. With even moderate appreciation in their share prices, investors should...
Published:
Wednesday's top analyst upgrades and downgrades included Abbott Laboratories, Boston Scientific, ChargePoint, Coinbase Global, Dollar General, Equitrans Midstream, Ford, Hasbro, Johnson & Johnson,...
Published:
Before U.S. markets open on Wednesday, these four companies are set to report quarterly earnings.
Published:
Thursday's top analyst upgrades and downgrades included Abbott Laboratories, Carnival, Deere, Delta Air Lines, DexCom, Enovix, First Republic Bank, GitLab, Hartford Financial Services, Interpublic...
Published:
U.S. equities are trading somewhat higher in Tuesday's premarket session as investors wait to hear what Federal Reserve chief Jerome Powell has to say to Congress.
Published:
With the potential for big downside still looming, and interest rates definitely headed higher, stock investors may want to consider these seven Dividend Aristocrats that posted solid third-quarter...
Published:
Thursday's top analyst upgrades and downgrades included Abbott Laboratories, Biohaven, Edwards Lifesciences, Enphase Energy, Halliburton, Invesco, Liberty Energy, Mattel, Netflix, Permian Resources,...
Published:
Here is a look at what to expect from these four companies when they report quarterly results before markets open on Wednesday.
Published:
With the potential for a serious downside move looming, and interest rates definitely headed higher, investors may want to consider the Dividend Aristocrats. These seven are in defensive sectors and...
Published:
After markets close Tuesday, video streaming giant Netflix will report quarterly earnings that are not expected to be a significant improvement over prior quarter results. Four other firms report...
Published:
Thursday's top analyst upgrades and downgrades included Abbott Laboratories, Azul, Boeing, Boston Scientific, Callon Petroleum, Corning, Datadog, Etsy, HCA Healthcare, Kohl's, Medtronic, Merck,...
Published:
In a market that is very volatile, and that could be headed much lower if we are already in a recession, these seven safe-haven stocks make a ton of sense now. With even moderate appreciation in the...
Published: